Hosted on MSN
IMF, World Bank Turn Bullish on India: Growth Outlook for FY26 Raised Amid Global Headwinds
After the World Bank, the International Monetary Fund has raised India's GDP growth forecast for India for FY25 from 6.4% to 6.6%. In its latest World Economic Outlook, the IMF upgraded India's GDP ...
By Anant Chandak BENGALURU, Feb 20 (Reuters) - India's private sector accelerated in February led by robust demand for goods ...
Indian GCCs now act as Centres of Excellence for finance, legal, and human resources, driving R&D in quantum computing, semiconductor design and AI, with end‑to‑end product life cycles often ...
As domestic demand spikes, Delhi is offering multibillion dollar investment opportunities across its entire energy value chain to accelerate growth and sustainability.
India’s renewable energy capacity now accounts for half of its electricity generation, five years ahead of target, yet coal still powers around 70% of its grid. The government aims for 500 GW of ...
BENGALURU (Reuters) -India's services sector growth accelerated to a 15-year high in August on robust demand, which also pushed prices higher at the fastest rate in over a decade, a business survey ...
Goldman Sachs projects India earnings to rebound 14% by 2026; explore investment opportunities in AI, China, and India now.
MUMBAI (Reuters) -Fitch Ratings has raised its forecast for India's economic growth for the current fiscal year to 6.9% from 6.5% earlier, citing stronger-than-expected momentum in the June quarter ...
RBI Governor notes global growth improvement by 2026 despite tensions. India`s economy is resilient with strong growth prospects and low inflation. Reserve Bank of India (RBI) governor Sanjay Malhotra ...
WASHINGTON, DC-India is the key growth engine for the world, the International Monetary Fund (IMF) said on January 15, noting that the country’s third-quarter growth came out stronger than expected.
Newsable Asianet News on MSN
India's healthcare sector to see stronger growth, US generics to lag
India's healthcare sector is poised for strong growth over the next 3 years, driven by new drug launches like GLP-1. However, earnings from the US generics market are expected to stay flat due to ...
This report is from the latest edition of CNBC's "Inside India" newsletter which brings you timely, insightful news and market commentary every week on the emerging powerhouse and the big businesses ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results